Daratumumab,Talquetamab,Teclistamab,Pomalidomide
janssen,genmab
['multiplemyeloma', 'teclistamab', 'janssen']
#janssen presents updated data at #eha22 for #teclistamab in patients with #relapsed or #refractory #multiplemyeloma 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.